SCHEMBL4558285

SCHEMBL4558285

CCOc1ccccc1C1CNCCN1CCCC(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.39
GLA P06280 2/20 0.39
HPGD P15428 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HSD17B10 Q99714 2/20 0.39
GAA P10253 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
HTR2A P28223 3/20 0.39
HTR2B P41595 3/20 0.39
HTR2C P28335 2/20 0.39
HCRTR2 O43614 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP2C19 P33261 1/20 0.38
S1PR5 Q9H228 2/20 0.38
SLC6A2 P23975 4/20 0.37
SLC6A4 P31645 4/20 0.37
SLC6A3 Q01959 3/20 0.37
POLB P06746 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11287256 0.81 SLC6A2 (0.44) HPGDALDH1A1HSD17B10HTR2AHTR2B
Hydrochloric Acid SCHEMBL6409887 0.76 HCRTR2 (0.38) KDM4EHSD17B10HTR2AHTR2BHTR2C
SCHEMBL5915126 0.73 DRD2 (0.51) HTR2AHTR2BHTR2CCYP2C19HTR1A
SCHEMBL11874335 0.72 SLC6A2 (0.38) HTR2AHTR2BHTR2CHCRTR2CYP2C19
SCHEMBL9527372 0.72 HTR2C (0.46) HTR2AHTR2BHTR2CCYP2C19SLC6A2
SCHEMBL7394555 0.71 SIGMAR1 (0.38) KDM4EALDH1A1CYP2C19SMN1; SMN2
SCHEMBL16150149 0.71 HTR2A (0.43) KDM4EGLAHPGDALDH1A1HSD17B10
SCHEMBL8223310 0.69 TAAR1 (0.43) HTR2AHTR2BHTR2C
SCHEMBL8757950 0.69 TAAR1 (0.41) HTR2AHTR2BHTR2C
Acetic Acid SCHEMBL27463978 0.69 KCNH2 (0.43) KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7488730-B2 N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-phenyl-1-piperazinealkylamide derivatives, and therapeutic use thereof as 5-HT7 receptor ligands UNIVERSITA DEGLI STUDI DI BARI (IT) 2009-02-10 US disclosed
US-20070117811-A1 N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-phenyl-1-piperazinealkylamide derivatives, and therapeutic use thereof as 5-HT7 receptor ligands UNIVERSITA DEGLI STUDI DI BARI (IT) 2007-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070117811-A1 N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-phenyl-1-piperazinealkylamide derivatives, and therapeutic use thereof as 5-HT7 receptor ligands HTR7, HTR3A, HTR1E KDM4E 1211/4885GLA 4679/4885HPGD 946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.